Australia markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
396.55-3.68 (-0.92%)
At close: 04:00PM EDT
396.20 -0.35 (-0.09%)
After hours: 07:50PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 102.53B
Enterprise value 92.12B
Trailing P/E 28.56
Forward P/E 24.33
PEG ratio (5-yr expected) 0.53
Price/sales (ttm)10.47
Price/book (mrq)5.83
Enterprise value/revenue 9.33
Enterprise value/EBITDA 20.00

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 321.00%
S&P500 52-week change 323.42%
52-week high 3448.40
52-week low 3316.43
50-day moving average 3416.72
200-day moving average 3380.98

Share statistics

Avg vol (3-month) 31.26M
Avg vol (10-day) 3889.07k
Shares outstanding 5258.46M
Implied shares outstanding 6258.46M
Float 8257.56M
% held by insiders 10.11%
% held by institutions 197.33%
Shares short (28 Mar 2024) 43.98M
Short ratio (28 Mar 2024) 43.84
Short % of float (28 Mar 2024) 41.54%
Short % of shares outstanding (28 Mar 2024) 41.54%
Shares short (prior month 29 Feb 2024) 44.05M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 324 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 36.68%
Operating margin (ttm)37.97%

Management effectiveness

Return on assets (ttm)13.17%
Return on equity (ttm)22.99%

Income statement

Revenue (ttm)9.87B
Revenue per share (ttm)38.30
Quarterly revenue growth (yoy)9.30%
Gross profit (ttm)N/A
EBITDA 4.48B
Net income avi to common (ttm)3.62B
Diluted EPS (ttm)13.88
Quarterly earnings growth (yoy)18.30%

Balance sheet

Total cash (mrq)11.22B
Total cash per share (mrq)43.43
Total debt (mrq)808.4M
Total debt/equity (mrq)4.60%
Current ratio (mrq)3.99
Book value per share (mrq)68.22

Cash flow statement

Operating cash flow (ttm)3.54B
Levered free cash flow (ttm)3.51B